Interleukin 2 and Interferon-gamma Activities of Mononuclear Cells from Regional Lymph Nodes in Patients with Gastric Cancer

Overview

Journal Gastroenterol Jpn

Specialty Gastroenterology

Date 1990 Jun 1

PMID 1972685

Citations 1

Authors

K Kusugami

T Matsuura

T Kawase

K Ina

H Matsunaga

Y Kuwahara

T Inagaki

K Morise

K Shimokata

Affiliations

Soon will be listed here.

Abstract

The interleukin 2 (IL-2) and interferon-gamma (IFN-gamma) activities of regional lymph node mononuclear cells (LNMC) were studied in 22 patients with gastric cancer. Regional LNMC could produce high levels of IL-2 and IFN-gamma independent of the disease extension or the location of the lymph nodes. The activities of peripheral blood mononuclear cells (PBMC) from cancer patients were decreased especially in advanced disease compared to controls. The lymph node CD4+ cells were responsible for the bulk of IL-2 activity, whereas both CD4+ and CD8+ cells were equally capable of producing IFN-gamma. The proportion of T cells in LNMC was similar to that seen in PBMC, however, CD4+ cells predominated over CD8+ cells in the lymph nodes, contributing to higher activities of IL-2 and IFN-gamma in LNMC. Furthermore, significant cytotoxic activity could be induced from PBMC using the culture supernatant derived from autologous LNMC in cancer patients. This study suggests that regional lymph nodes are strategically located near the tumor and the local cells are capable of producing high levels of IL-2 and IFN-gamma.

Citing Articles

Impaired regulation of natural killer cells in immunoglobulin synthesis by peripheral blood mononuclear cells from patients with ulcerative colitis.

Kawase T, Kusugami K, Matsunaga H, Matsuura T, Morise K Gastroenterol Jpn. 1990; 25(5):585-92.

PMID: 2121577 DOI: 10.1007/BF02779358.

References

Akiyoshi T, Koba F, Kikuchi T, Arinaga S, Tsuji H . Production of interleukin 2 by human lymph nodes. Immunobiology. 1987; 174(3):360-4. DOI: 10.1016/S0171-2985(87)80010-4. View

Kusugami K, Youngman K, West G, Fiocchi C . Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. Gastroenterology. 1989; 97(1):1-9. DOI: 10.1016/0016-5085(89)91408-x. View

Koba F, Akiyoshi T, Arinaga S, Wada T, Tsuji H . Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma. Jpn J Surg. 1987; 17(2):83-90. DOI: 10.1007/BF02470646. View

Vose B, Vanky F, Klein E . Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells. Int J Cancer. 1977; 20(6):895-902. DOI: 10.1002/ijc.2910200612. View

Luger T, Smolen J, Chused T, Steinberg A, Oppenheim J . Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest. 1982; 70(2):470-3. PMC: 371256. DOI: 10.1172/jci110637. View

Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T . Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. J Immunol. 1985; 134(1):187-95. View

Shimokata K . Studies on the pathogenicity of human-origin parainfluenza virus in the brain of mice. Microbiol Immunol. 1978; 22(9):535-43. DOI: 10.1111/j.1348-0421.1978.tb00401.x. View

Henney C, Kuribayashi K, Kern D, Gillis S . Interleukin-2 augments natural killer cell activity. Nature. 1981; 291(5813):335-8. DOI: 10.1038/291335a0. View

Kuwahara Y, Kusugami K, Morise K, Shimokata K . Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer. Gastroenterol Jpn. 1987; 22(4):428-34. DOI: 10.1007/BF02773809. View

10.

Matsunaga H, Kuwahara Y, Kusugami K, Morise K, Shimokata K . Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer. Gastroenterol Jpn. 1988; 23(5):527-33. DOI: 10.1007/BF02779484. View

11.

Ip S, Rittershaus C, Healey K, Struzziero C, Hoffman R, Hansen P . Rapid enumeration of T lymphocytes by a flow-cytometric immunofluorescence method. Clin Chem. 1982; 28(9):1905-9. View

12.

Antonelli P, Stewart 2nd W, DuPont B . Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparation. Clin Immunol Immunopathol. 1981; 19(2):161-9. DOI: 10.1016/0090-1229(81)90059-3. View

13.

Kasahara T, Hooks J, Dougherty S, Oppenheim J . Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol. 1983; 130(4):1784-9. View

14.

Bonilla F, Alvarez-Mon M, Merino F, de la Hera A, Ales J, Espana P . Interleukin-2 induces cytotoxic activity in lymphocytes from regional axillary nodes of breast cancer patients. Cancer. 1988; 61(4):629-34. DOI: 10.1002/1097-0142(19880215)61:4<629::aid-cncr2820610402>3.0.co;2-v. View

15.

Grimm E, Mazumder A, Zhang H, Rosenberg S . Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med. 1982; 155(6):1823-41. PMC: 2186695. DOI: 10.1084/jem.155.6.1823. View

16.

Mori S, Mohri N, Morita H, Maeda H, Uchiyama T, Yamaguchi K . Distribution of lymphocyte subsets in human perigastric lymph nodes. Nihon Ketsueki Gakkai Zasshi. 1984; 47(1):89-99. View

17.

Shimokata K, Kishimoto H, Takagi E, Tsunekawa H . Determination of the T-cell subset producing gamma-interferon in tuberculous pleural effusion. Microbiol Immunol. 1986; 30(4):353-61. DOI: 10.1111/j.1348-0421.1986.tb00952.x. View

18.

Kajitani T . The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg. 1981; 11(2):127-39. DOI: 10.1007/BF02468883. View

19.

Shiiba K, Suzuki R, Kawakami K, Ohuchi A, Kumagai K . Interleukin 2-activated killer cells: generation in collaboration with interferon gamma and its suppression in cancer patients. Cancer Immunol Immunother. 1986; 21(2):119-28. PMC: 11038538. DOI: 10.1007/BF00199859. View

20.

Nakayama E, Asano S, Takuwa N, Yokota J, Miwa S . Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer. Clin Exp Immunol. 1983; 51(3):511-6. PMC: 1536770. View